Estrogen receptor: Structural differences and potential implications on selectivity examined by the GRID/CPCA approach


Autoria(s): MENEZES, I. R. A. de; LEITAO, A.; MONTANARI, C. A.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2008

Resumo

Selective Estrogen Receptor Modulators ( SERMs) have been developed, but the selectivity towards the subtypes ( ER or ER is not well understood. Based on three-dimensional structural properties of ligand binding domains, a model that takes into account this aspect was developed via molecular interaction fields and consensus principal component analysis (GRID/CPCA).

Identificador

LETTERS IN DRUG DESIGN & DISCOVERY, v.5, n.3, p.182-192, 2008

1570-1808

http://producao.usp.br/handle/BDPI/31762

10.2174/157018008784083947

http://dx.doi.org/10.2174/157018008784083947

Idioma(s)

eng

Publicador

BENTHAM SCIENCE PUBL LTD

Relação

Letters in Drug Design & Discovery

Direitos

closedAccess

Copyright BENTHAM SCIENCE PUBL LTD

Palavras-Chave #ER subtypes #consensus PCA #selective estrogen receptor modulators #SERM #ligand binding domain #key interactions #LIGAND-BINDING DOMAIN #BREAST-CANCER #BIOLOGICAL EVALUATION #ANALYTICAL SHAPE #QSAR ANALYSIS #DRUG DESIGN #ALPHA #BETA #SITE #ANTIESTROGENS #Chemistry, Medicinal
Tipo

article

original article

publishedVersion